MET and neoplasm: So far, the best efficacy observed was based on SQ tumor model, by which one-time intra-tumoral injection of MET-CAR.CD28ζ T cells induced tumor regression without showing recurrence (Fig. 7), which is more potent than other reported MET-CARs requiring multiple injections at tumor site to be effective [43, 44].